Asia Pacific MRI (Magnetic Resonance Imaging) Market is expected to reach US$ 3.77 Bn. by 2027, at a CAGR of 2.20% during the forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report An MRI also was known as magnetic resonance imaging scan is a special radiology technique that uses magnetism, radio waves, and a computer to produce images of different body structures. The image as well as the resolution produced by MRI is quite detailed and can even detect tiny changes of structures occurring within the body. For certain procedures, contrast agents, such as gadolinium, are also used to enhance the accuracy of the images. An MRI scan is used as an extremely accurate method of disease detection present throughout the body and are often able to provide sufficient information confirming a patient's diagnosis. Especially in the head, any form of trauma to the brain such as bleeding or swelling are detected using MRI. Other abnormalities include brain aneurysms, stroke, tumours of the brain, as well as tumours or inflammation of the spine along with other neurological diseases have resulted in brain and neurological MRI holding a significant share of the overall Asia Pacific MRI (Magnetic Resonance Imaging) Market. Neurosurgeons use MRI scan not only for defining brain anatomy but also for evaluating the reliability of the spinal cord after trauma. An MRI scan can further help evaluate the structure of the heart and aorta for detecting aneurysms or tears with the cardiac segment forming another major application area for the MRI market in the Asia Pacific. It provides valuable facts on glands and organs within the abdomen, and precise information about the structure of the joints, soft tissues, or bones present in the body. Often, surgeries are more accurately directed after knowing the results of an MRI scan. Metallic chips, materials, surgical clips, or any foreign material such as artificial joints or prosthetic devices may significantly distort the images obtained by the MRI scanner forming a key restraint for the market. The Asia Pacific is one of the major markets for MRI globally where China and India among others are the two major regions profiled under Asia Pacific MRI (Magnetic Resonance Imaging) Market report. Changing healthcare infrastructure along with the probabilities of achieving a desired patient information are certain key contributing factors to boost the market for Asia Pacific MRI (Magnetic Resonance Imaging) Market.
Asia Pacific MRI (Magnetic Resonance Imaging) Market, Key Highlights:
• Asia Pacific MRI (Magnetic Resonance Imaging) Market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Asia Pacific MRI market • Asia Pacific MRI (Magnetic Resonance Imaging) Market segmentation on the basis of application, architecture, field strength, and geography • Asia Pacific MRI (Magnetic Resonance Imaging) Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of a study • Asia Pacific MRI (Magnetic Resonance Imaging) Market analysis and forecast for major countries have been provided. • Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies • Competitive landscape of the key players operating in the Asia Pacific MRI (Magnetic Resonance Imaging) Market including competitive developments, investments, and strategic expansionAsia Pacific MRI (Magnetic Resonance Imaging) Market, Geographic Analysis:
• Breakdown of China MRI market • Breakdown of Japan MRI market • Breakdown of India MRI market • Breakdown of South Korea MRI market • Breakdown of Australia MRI marketAsia Pacific MRI (Magnetic Resonance Imaging) Market Scope: Inquire before buying
Asia Pacific MRI (Magnetic Resonance Imaging) Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2027 Historical Data: 2017 to 2021 Market Size in 2021: US$ 3.31 Bn. Forecast Period 2022 to 2027 CAGR: 2.20% Market Size in 2027: US$ 3.77 Bn. Segments Covered: by Application • Spine and musculoskeletal MRI • Brain and neurological MRI • Vascular MRI • Pelvic and Abdominal MRI • Breast MRI • Cardiac MRI by Architecture • Open MRI Systems • Closed MRI Systems • Standard Bore • Wide Bore by Field Strength • Low-to-mid Field • High-field • 1.5T • 3T • Very-high Field Asia Pacific MRI (Magnetic Resonance Imaging) Market, by Geography:
• Asia Pacific • China • Japan • India • South Korea • AustraliaAsia Pacific MRI (Magnetic Resonance Imaging) Market Key Players:
• Neusoft Medical • Ningbo Xingaoyi Magnetism Co. Ltd • GE Healthcare • Philips Healthcare • Siemens Healthcare • ANKE Medical • Fujifilm Holdings • Shimadzu Corporation • Toshiba Medical Systems Corporation • Carestream Health • Hitachi Medical Corporation • Esaote • Green Medical Co., LTD • Mitsubishi Research Institute, Inc. • Fair Medical Co Ltd. Japan • JAPAN CARE CO., LTD • Sanrad Medical Systems • Medirays Corporation • MRI Services • Edge Medical Solutions • Blue Star • Alpenglow Australia • I-MED Radiology Network • MRI e-cycle solutions • Voyager Imaging • MRI Now • Resonance Health • Magnetica Frequently Asked Questions: 1. Which region has the largest share in Asia Pacific MRI (Magnetic Resonance Imaging) Market? Ans: China region holds the highest share in 2021. 2. What is the growth rate of Asia Pacific MRI (Magnetic Resonance Imaging) Market? Ans: The Asia Pacific MRI (Magnetic Resonance Imaging) Market is growing at a CAGR of 2.20% during forecasting period 2022-2027. 3. What is scope of the Asia Pacific MRI (Magnetic Resonance Imaging) market report? Ans: Asia Pacific MRI (Magnetic Resonance Imaging) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Asia Pacific MRI (Magnetic Resonance Imaging) market? Ans: The important key players in the Asia Pacific MRI (Magnetic Resonance Imaging) Market are – Neusoft Medical, Ningbo Xingaoyi Magnetism Co. Ltd, GE Healthcare, Philips Healthcare, Siemens Healthcare, ANKE Medical, Fujifilm Holdings, Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation, and Esaote. 5. What is the study period of this market? Ans: The Asia Pacific MRI (Magnetic Resonance Imaging) Market is studied from 2021 to 2027.
Asia Pacific MRI (Magnetic Resonance Imaging) Market
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET VARIABLES SCOPE 3.1. Market Segmentation Scope 3.2. Market Driver Analysis 3.3. Market Restraint Analysis 3.4. Porter’s Five Forces Analysis 3.5. PESTLE Analysis 4. ASIA PACIFIC MRI ARCHITECTURE ESTIMATES TREND ANALYSIS (2021-2027) 4.1. MRI (Magnetic Resonance Imaging) Market: Architecture Analysis 4.2. Open MRI Systems 4.2.1. Open MRI Systems market, 2021-2027 (USD Billion) 4.3. Closed MRI Systems 4.3.1. Closed MRI Systems market, 2021-2027 (USD Billion) 4.4. Standard Bore 4.4.1. Standard Bore market, 2021-2027 (USD Billion) 4.5. Wide Bore 4.5.1. Wide Bore market, 2021-2027 (USD Billion) 5. ASIA PACIFIC MRI FIELD STRENGTH ESTIMATES TREND ANALYSIS (2021-2027) 5.1. MRI (Magnetic Resonance Imaging) Market: Field Strength Analysis 5.2. Low-to-mid Field MRI 5.2.1. Low-to-mid Field MRI market, 2021-2027 (USD Billion) 5.3. High-field MRI 5.3.1. High-field MRI market, 2021-2027 (USD Billion) 5.4. 1.5T MRI 5.4.1. 1.5T MRI market, 2021-2027 (USD Billion) 5.5. 3T MRI 5.5.1. 3T MRI market, 2021-2027 (USD Billion) 5.6. Very-high Field MRI 5.6.1. Very-high Field MRI market, 2021-2027 (USD Billion) 6. ASIA PACIFIC MRI APPLICATION ESTIMATES TREND ANALYSIS (2021-2027) 6.1. MRI (Magnetic Resonance Imaging) Market: Application Analysis 6.2. Spine and musculoskeletal MRI 6.2.1. Spine and musculoskeletal MRI market, 2021-2027 (USD Billion) 6.3. Brain and neurological MRI 6.3.1. Brain and neurological MRI market, 2021-2027 (USD Billion) 6.4. Vascular MRI 6.4.1. Vascular MRI market, 2021-2027 (USD Billion) 6.5. Pelvic and Abdominal MRI 6.5.1. Pelvic and Abdominal MRI market, 2021-2027 (USD Billion) 6.6. Breast MRI 6.6.1. Breast MRI market, 2021-2027 (USD Billion) 6.7. Cardiac MRI 6.7.1. Cardiac MRI market, 2021-2027 (USD Billion) 7. REGIONAL ESTIMATES TREND ANALYSIS (2021-2027) 7.1. MRI market share by country, 2016 2024 7.2. China 7.2.1. China MRI market, 2021-2027 (USD billion) 7.3. Japan 7.3.1. Japan MRI market, 2021-2027 (USD billion) 7.4. India 7.4.1. India MRI market, 2021-2027 (USD billion) 7.5. South Korea 7.5.1. South Korea MRI market, 2021-2027 (USD billion) 7.6. Australia 7.6.1. Australia MRI market, 2021-2027 (USD billion) 8. MARKET SHARE ANALYSIS 8.1. Regional MRI Market Share Analysis, by Key Players 8.1.1. China MRI Market Share Analysis, by Key Players 8.1.2. Japan MRI Market Share Analysis, by Key Players 8.1.3. India MRI Market Share Analysis, by Key Players 8.1.4. South Korea MRI Market Share Analysis, by Key Players 8.1.5. Australia MRI Market Share Analysis, by Key Players 8.2. MRI Market: Key Innovators 8.3. Patent Analysis Year 2017 9. MARKET COMPETITION ANALYSIS 9.1. Strategy Framework 9.2. Company Profiles 9.2.1. Neusoft Medical 9.2.1.1. Company overview 9.2.1.2. Key financials 9.2.1.3. Product landscape 9.2.1.4. Strategic initiatives 9.2.1.5. SWOT analysis 9.2.2. Ningbo Xingaoyi Magnetism Co. Ltd 9.2.2.1. Company overview 9.2.2.2. Key financials 9.2.2.3. Product landscape 9.2.2.4. Strategic initiatives 9.2.2.5. SWOT analysis 9.2.3. GE Healthcare 9.2.3.1. Company overview 9.2.3.2. Key financials 9.2.3.3. Product landscape 9.2.3.4. Strategic initiatives 9.2.3.5. SWOT analysis 9.2.4. Philips Healthcare 9.2.4.1. Company overview 9.2.4.2. Key financials 9.2.4.3. Product landscape 9.2.4.4. Strategic initiatives 9.2.4.5. SWOT analysis 9.2.5. Siemens Healthcare 9.2.5.1. Company overview 9.2.5.2. Key financials 9.2.5.3. Product landscape 9.2.5.4. Strategic initiatives 9.2.5.5. SWOT analysis 9.2.6. ANKE Medical 9.2.6.1. Company overview 9.2.6.2. Key financials 9.2.6.3. Product landscape 9.2.6.4. Strategic initiatives 9.2.6.5. SWOT analysis 9.2.7. Fujifilm Holdings 9.2.7.1. Company overview 9.2.7.2. Key financials 9.2.7.3. Product landscape 9.2.7.4. Strategic initiatives 9.2.7.5. SWOT analysis 9.2.8. Shimadzu Corporation 9.2.8.1. Company overview 9.2.8.2. Key financials 9.2.8.3. Product landscape 9.2.8.4. Strategic initiatives 9.2.8.5. SWOT analysis 9.2.9. Toshiba Medical Systems Corporation 9.2.9.1. Company overview 9.2.9.2. Key financials 9.2.9.3. Product landscape 9.2.9.4. Strategic initiatives 9.2.9.5. SWOT analysis 9.2.10. Carestream Health 9.2.10.1. Company overview 9.2.10.2. Key financials 9.2.10.3. Product landscape 9.2.10.4. Strategic initiatives 9.2.10.5. SWOT analysis 9.2.11. Hitachi Medical Corporation 9.2.11.1. Company overview 9.2.11.2. Key financials 9.2.11.3. Product landscape 9.2.11.4. Strategic initiatives 9.2.11.5. SWOT analysis 9.2.12. Esaote 9.2.12.1. Company overview 9.2.12.2. Key financials 9.2.12.3. Product landscape 9.2.12.4. Strategic initiatives 9.2.12.5. SWOT analysis 9.2.13. Green Medical Co., LTD 9.2.13.1. Company overview 9.2.13.2. Key financials 9.2.13.3. Product landscape 9.2.13.4. Strategic initiatives 9.2.13.5. SWOT analysis 9.2.14. Mitsubishi Research Institute, Inc. 9.2.14.1. Company overview 9.2.14.2. Key financials 9.2.14.3. Product landscape 9.2.14.4. Strategic initiatives 9.2.14.5. SWOT analysis 9.2.15. Fair Medical Co Ltd. 9.2.15.1. Company overview 9.2.15.2. Key financials 9.2.15.3. Product landscape 9.2.15.4. Strategic initiatives 9.2.15.5. SWOT analysis 9.2.16. JAPAN CARE CO., LTD 9.2.16.1. Company overview 9.2.16.2. Key financials 9.2.16.3. Product landscape 9.2.16.4. Strategic initiatives 9.2.16.5. SWOT analysis 9.2.17. Sanrad Medical Systems 9.2.17.1. Company overview 9.2.17.2. Key financials 9.2.17.3. Product landscape 9.2.17.4. Strategic initiatives 9.2.17.5. SWOT analysis 9.2.18. Medirays Corporation 9.2.18.1. Company overview 9.2.18.2. Key financials 9.2.18.3. Product landscape 9.2.18.4. Strategic initiatives 9.2.18.5. SWOT analysis 9.2.19. MRI Services 9.2.19.1. Company overview 9.2.19.2. Key financials 9.2.19.3. Product landscape 9.2.19.4. Strategic initiatives 9.2.19.5. SWOT analysis 9.2.20. Edge Medical Solutions 9.2.20.1. Company overview 9.2.20.2. Key financials 9.2.20.3. Product landscape 9.2.20.4. Strategic initiatives 9.2.20.5. SWOT analysis 9.2.21. Blue Star 9.2.21.1. Company overview 9.2.21.2. Key financials 9.2.21.3. Product landscape 9.2.21.4. Strategic initiatives 9.2.21.5. SWOT analysis 9.2.22. Alpenglow Australia 9.2.22.1. Company overview 9.2.22.2. Key financials 9.2.22.3. Product landscape 9.2.22.4. Strategic initiatives 9.2.22.5. SWOT analysis 9.2.23. I-MED Radiology Network 9.2.23.1. Company overview 9.2.23.2. Key financials 9.2.23.3. Product landscape 9.2.23.4. Strategic initiatives 9.2.23.5. SWOT analysis 9.2.24. MRI e-cycle solutions 9.2.24.1. Company overview 9.2.24.2. Key financials 9.2.24.3. Product landscape 9.2.24.4. Strategic initiatives 9.2.24.5. SWOT analysis 9.2.25. Voyager Imaging 9.2.25.1. Company overview 9.2.25.2. Key financials 9.2.25.3. Product landscape 9.2.25.4. Strategic initiatives 9.2.25.5. SWOT analysis 9.2.26. MRI Now 9.2.26.1. Company overview 9.2.26.2. Key financials 9.2.26.3. Product landscape 9.2.26.4. Strategic initiatives 9.2.26.5. SWOT analysis 9.2.27. Resonance Health 9.2.27.1. Company overview 9.2.27.2. Key financials 9.2.27.3. Product landscape 9.2.27.4. Strategic initiatives 9.2.27.5. SWOT analysis 9.2.28. Magnetica 9.2.28.1. Company overview 9.2.28.2. Key financials 9.2.28.3. Product landscape 9.2.28.4. Strategic initiatives 9.2.28.5. SWOT analysis
